Clinical Development Hub
Local Demo
Home/safety/follow up

Safety Follow-Up

Follow-up collection and case completeness assurance. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.

Safety Follow-Up Progress

Follow-Ups Open
2,213
Past Due
312
Case Complete %
88%

Missing Data Follow-Ups

ItemDetails
CTIS-00001 | STUDY-0001 | USSubmission | due 2026-01-01 | RFI-4900
CTIS-00002 | STUDY-0002 | CARFI | due 2026-02-02 | RFI-4901
CTIS-00003 | STUDY-0003 | GBSubstantial Modification | due 2026-03-03 | RFI-4902
CTIS-00004 | STUDY-0004 | DEValidation | due 2026-04-04 | RFI-4903
CTIS-00005 | STUDY-0005 | FRResults Prep | due 2026-05-05 | RFI-4904
CTIS-00006 | STUDY-0006 | ESSubmission | due 2026-06-06 | RFI-4905
CTIS-00007 | STUDY-0007 | ITValidation | due 2026-07-07 | RFI-4906
CTIS-00008 | STUDY-0008 | NLRFI | due 2026-08-08 | RFI-4907
CTIS-00009 | STUDY-0009 | BERFI | due 2026-09-09 | RFI-4908
CTIS-00010 | STUDY-0010 | SESubstantial Modification | due 2026-10-10 | RFI-4909
Access & Governance Controls
RBAC+ABACStudy Firewall ActiveRestricted Zone

Operational Controls

Study firewalling chips highlight boundary, country constraints, and vendor partition rules.

Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.

Every state change writes immutable audit evidence with actor, timestamp, and object reference.

Next Actions

Filter to portfolio/program/study context.

Open linked tasks, risks, and document evidence.

Escalate blocked items through governed workflow.